A Phase 1 Trial of Oncolytic Measles Virotherapy in Mesothelioma
Latest Information Update: 07 Nov 2021
At a glance
- Drugs MV NIS (Primary)
- Indications Malignant-mesothelioma
- Focus Adverse reactions
- 08 Jan 2021 Status changed from active, no longer recruiting to completed.
- 02 Jan 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 02 Jan 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.